Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Apogee Therapeutics, Inc.

Clinical trials sponsored by Apogee Therapeutics, Inc., explained in plain language.

Apogee Therapeutics, Inc. APGE NASDAQ

A biotech company developing antibody therapies for inflammatory and immunologic diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 3

New eczema drug shows promise in Long-Term trial

Disease control Recruiting now

This study is for people with moderate-to-severe eczema who have already completed a previous APG777 trial. It aims to see if APG777 is safe and works well over a longer period. Participants will receive injections of the drug every 12 or 24 weeks and be monitored for side effect…

Phase: PHASE2 • Sponsor: Apogee Therapeutics, Inc. • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC